The Science of the Deal

October, 2020    SMM-218 The Science of the Deal This article describes the early findings from my work with Zaki Sallem, one of the Doctoral Candidates I supervise. It gives new insight into what drives and shapes the construction of IP deals in...

Bayer’s Drop of the Future

October, 2020    SMM-219 Bayer’s Drop of the Future With the rising importance of the ‘patient payer,’ the Bayer/One Drop business model brings together capabilities that neither firm possesses in full. Not only did this confirm...